Wearable Injectors Market Analysis

  • Report ID: 3300
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Wearable Injectors Market Analysis

The market is segmented on the basis of type into on-body and off-body, out of which the on-body segment is anticipated to grab the largest share by the end of 2030 on account of the increasing demand for this type of injector owing to the presence of multiple features. In addition, on-body wearable injectors are comfortable to be worn on the skin, along with their water-resistant capability and ease of use at home, which is also projected to contribute to the growth of the segment during the forecast period. Additionally, the off-body injector segment is also expected to grow significantly in the years to come as these devices reduce the problems such as adhesive fitting issues, painful removal and skin sensitivity. 

Based on end-user, the home care settings segment in the wearable injectors market is projected to grow with a significant CAGR over the forecast period, which can be attributed to the surge in preference for self-administration of drugs and the rise in the development of advanced drug delivery options, which minimize the need for technical expertise while administering medications. Additionally, the restrictions posed by COVID-19 outbreak has also resulted in the rising adoption of self-administration of drugs in-home care settings, especially by the vulnerable groups such as the geriatric population, which is also expected to support the market growth.

Our in-depth analysis of the global market includes the following segments:

           Type

  • On-Body
  • Off-Body

             End-User

  • Medical Hospitals
  • Clinics
  • Home Care Settings
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3300
  • Published Date: Aug 29, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of wearable injectors is evaluated at USD 9.36 billion.

Wearable Injectors Market size was valued at USD 8.63 billion in 2023 and is set to cross USD 31.98 billion by 2036, expanding at more than 10.6% CAGR during the forecast period i.e., between 2024-2036. The rising prevalence of chronic medical conditions and the technological developments in drug delivery injectors globally will fuel the market growth.

Asia Pacific is likely to dominate majority revenue share by 2036, owing to large elderly population in many countries of the region such as China and Japan, and the increasing prevalence of chronic disorders in the region.

The major players in the market include Amgen Inc., Insulet Corporation, YPSOMED AG, among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample